Mycoplasma pneumoniae 感染症の心臓症状: 2007年から2024年のコホート研究
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。Mycoplasma pneumoniae (MP) 感染症の心臓合併症は,これまで考えられていたよりも多く,成人の17%に影響します. MPに関連する心臓疾患は 発症率と死亡率を高め,重症の場合 早期の心臓診断が必要になります.
科学分野
- 感染症
- 心臓病科
- クリティカル ケア 医療
背景
- ミコプラズマ肺炎 (MP) 感染症は典型的には呼吸器系ですが,肺外の問題を引き起こすことがあります.
- MP感染における心臓の関与は歴史的に稀であったが,最近のデータは,特にICU患者において,より高い割合を示唆している.
研究 の 目的
- MP感染の入院患者における心臓症状の流行,臨床スペクトル,アウトカムを決定する.
- MP感染における心臓関わりの増加とリスクを強調する.
主な方法
- 2007年から2024年半ばまで,イスラエルのエルサレムにあるHadassah医療センターでコホート研究が行われました.
- MPのPCRが陽性だった入院患者も含まれていた.
- 心臓発作は,充血性心不全 (CHF),不律性,急性冠動脈症候群 (ACS),周辺/心筋炎,または単発的なトロポニン上昇として定義された.
主要な成果
- MP陽性患者1305人のうち11. 6%が心動脈に罹患した (17%が成人,4. 9%が小児).
- 成人では,心筋梗塞と心律不整が最も頻繁に (34. 7%) 発生し,その後は,心周/心筋炎 (15. 3%) とACS (10. 5%) であった.
- 心臓病にかかわる成人の病院での死亡率は高かった (22.6%),ICU入院,高齢化,非MPの初診は死亡率の予測要因であった.
結論
- MP感染した入院した成人の心臓の関わりは,以前に認められたものより多く (17%) であり,有意な罹病率と死亡率と関連しています.
- MPに感染した入院患者,特に重症または原因不明の心臓症状のある患者には,早期の心臓診断が不可欠です.
関連する概念動画
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...